Jim Daly

Jim Daly has over 30 years of experience leading US and global businesses in the biopharmaceutical industry and currently serves as a Director of ACADIA Pharmaceuticals, Halozyme Therapeutics, argenx, and Madrigal Pharmaceuticals. Most recently, Mr Daly served as Executive Vice President and Chief Commercial Officer at Incyte Corporation from 2012 to 2015, where he was instrumental in commercializing and driving product growth of Jakafi®. Previously, Mr Daly worked for Amgen, Inc, and held various leadership positions over a 10-year period, including Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development, and Vice President and General Manager of the Oncology Business Unit. Earlier in his career, he spent over 16 years with Glaxo Wellcome/GlaxoSmithKline (GSK) where he held roles of increasing responsibility, including Senior Vice President, General Manager, Respiratory and Anti-Infective Business Unit. He earned a BS in Pharmacy and an MBA from the University at Buffalo, The State University of New York.